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Cymbopogon citratus has been shown to have antioxidant, antimicrobial, antispasmodic and chemo-protective properties. Citral, is
the major constituent of C. citratus. This study investigated the eﬀects of methanolic extracts of leaves (LE), stems (SE), and roots
(RE) of C. citratus and citral on vascular smooth muscle and explored their possible mechanisms of action. The experiment was
conducted using isolated tissue preparations, where citral, LE, SE, and RE were added separately into a tissue bath that contained
aortic rings, which were pre-contracted with phenylephrine (PE). Citral, LE, and RE exhibited a dose-dependent relaxant eﬀect on
the PE-induced contractions. Citral appeared to partially act via NO as its vasorelaxant eﬀect was attenuated by L-NAME.However,
the eﬀect of LE may involve prostacyclin as indomethacin reversed the relaxant eﬀect of LE on the PE-induced contraction.
Furthermore, citral, LE, and RE abolished the restoration of PE-induced contraction caused by the addition of increasing doses
of calcium in both endothelium intact and denuded rings. These findings suggest that the relaxation eﬀect of citral, LE, and RE
is endothelium-independent and may be mainly by aﬀecting the intracellular concentration of calcium. Citral may partially act
through the NO pathway while a vasodilator prostaglandin may mediate the eﬀect of LE.
1. Introduction
Cymbopogon citratus, commonly known as lemongrass, is a
tropical perennial herb belonging to the family Poaceae (true
grasses). It is commonly used in traditional Indian, Chinese,
and Brazilian medicines [1]. Cymbopogon citratus has been
shown to be eﬀective in the treatment of fever and infection,
headaches, stomach aches, and rheumatic pain [2]. It is also
reported to act as a sedative [2], antispasmodic [3], analgesic,
anti-inflammatory [4], and antihypertensive [5] agents.
However, the scientific evidence for its alleged therapeutic
eﬃcacy is still lacking. Furthermore, many of these reports
concerning the eﬀect of C. citratus described the function of
only one particular part of the plant. The leaves decoction,
for example, has been shown to have antioxidant property
[6]. Meanwhile the stalk or stem of C. citratus was reported
to have a small relaxation eﬀect on perfused mesenteric
arteries [7]. In this study we report the comparative eﬀects of
methanolic extracts of various parts of the plant on vascular
smooth muscle.
It is widely accepted that natural products of plant origin
comprised a variety of components, and generally the major
component is found to reflect well the biophysiological
features of the extracts [8]. Phytochemical investigation of
C. citratus showed that citral, 3-7-dimethyl-2,6-octadienal,
is the major component of C. citratus [9, 10] and it is the
most important member of the open-chainmonoterpenoids.
Studies have shown citral to be positive as anticlastogenic and
anticancer agent [10, 11].
Most studies on natural products or drug receptor to
signal transduction cascades, have used rats as the standard
experimental animal model [12]. Similarly, studies on anti-
hypertensive properties of plant extracts or natural products
usually used rats, typically the spontaneously hypertensive
rats (SHR) and their normotensive counterpart, Wistar-
Kyoto (WKY) rats. The SHR strain is the most studied model
of hypertension and cardiovascular diseases [13, 14]. As this
strain was obtained by selective breeding of WKY rats,
therefore, in all subsequent studies, WKY rats have been
employed as controls for SHR [15]. Furthermore, studies
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involving vasodilatation or specifically vascular smooth
muscles are often performed using isolated blood vessels.
Isolated blood vessel pharmacology research allows scientists
to explore mechanisms of action and to establish dose-
response relationship for the analysis of the relative potency
and eﬃcacy of the drugs. Such studies also provide informa-
tion in a controlled environment, without interference from
changes in blood flow and sheer stress, extrinsic neural, or
hormonal activity [16]. Isolated arterial ring preparations,
commonly prepared from the rat aorta (thoracic region),
are popular because aortic segments are relatively hardy and
easily prepared [17].
Since we have previously reported a relaxant eﬀect of
citral and the extracts from C. citratus on visceral smooth
muscle [3], the present study was aimed at investigating their
eﬀects on vascular smoothmuscle and consequently provides
further evidence for the antihypertensive eﬀects of these test
materials. The objective of the present study was therefore to
examine the eﬀects of citral andmethanolic extracts of leaves,
stems, and roots from C. citratus on the contraction of rat
aortic rings. In addition, attempts were made to determine
the mechanisms by which the test materials produce their
respective vascular responses.
2. Methods
2.1. Ethical Approval. All the experimental procedures
performed in this study were approved by the Animal
Care and Use Committee of the Faculty of Medicine,
University of Malaya (Reference number FIS/07/12/2006/
RI(R)).
2.2. Drugs and Chemicals. For the extraction process,
methanol was purchased from Merck, Germany. Meanwhile,
for the in vitro aortic ring experiments the following
chemicals were obtained from Sigma Chemical Co., USA:
phenylephrine hydrochloride (PE), acetylcholine chloride
(ACh), Nω-nitro-L-arginine methyl ester hydrochloride (L-
NAME), indomethacin, and ethylenediaminetetraacetic acid
disodium salt (EDTA). A stock solution of each drug except
indomethacin, was prepared and diluted to the desired con-
centrations in distilled water. Dilution of indomethacin was
prepared in 0.05% (w/v) Na2CO3. All drugs were prepared
fresh on the day of the experiment. The concentrations of
the drugs were expressed as the final molar concentration
contained in the tissue bath. Krebs solution, pH 7.4, contains
(mM) NaCl (118.0), KCl (4.7), KH2PO4 (1.2), CaCl2·2H20
(2.6), NaHCO3 (25.0), MgSO4·7H2O (1.2), and glucose
(11.1). The composition of Ca2+-free Krebs solution was
similar to that of the normal Krebs solution but with EDTA
0.2mM instead of CaCl2·2H2O.
Citral was purchased from Sigma Chemical Co., USA. A
stock solution of citral was prepared in 2% (v/v) methanol in
order to improve its miscibility in aqueous solution [3]. Test
solution of citral was prepared fresh from the stock solution
before each experiment, and the range of concentrations
used in this study was from 0.00624mM (0.0001%) to
6.24mM (0.1%).
2.3. Plant Materials. Stalks of C. citratus were collected in
the rural area of Beranang, Kajang, and the sample voucher
(KLU 045309) was deposited in the Herbarium, Faculty of
Science, University of Malaya.
2.3.1. Plant Extraction. The collected C. citratus was cleaned
and isolated into leaves, stems, and roots. They were
separately oven-dried at 65◦C and coarsely ground. The
powdered materials of C. citratus (100 g) were extracted with
1000mL of 70% methanol for 3 days with occasional shak-
ing. A mixture of each part of the plant was filtered through
Whatman qualitative grade 1 filter paper and this procedure
was repeated 3 times. The extracts were then evaporated on
a rotary evaporator (Gucci, Germany) at 40◦C to eliminate
the methanol. The extracts were then lyophilised and stored
at −20◦C until used. The yields were 12.34 g, 14.38 g, and
11.68 g, respectively, for the leaves (LE), stems (SE), and roots
(RE). The powdered extracts were reconstituted with distilled
water to the desired concentrations prior to use.
2.4. Animals. Male spontaneously hypertensive rats (SHRs)
and Wistar Kyoto rats (WKY), weighing 250 to 300 g, were
obtained from the University of Malaya Laboratory Animal
Centre. The rats were kept in cages (5 per cage) and were
comfortably maintained under controlled conditions. They
were provided with normal rat chow (Gold Coin Feed Mills
Sdn. Bhd., Malaysia) and water ad libitum. All rats were
allowed to acclimatize in the animal holding room for a
minimum period of two weeks before being used for any
experiment.
2.4.1. Preparation of Rat Aortic Rings. The rats were killed
by cervical dislocation, and the thoracic aorta was isolated
according to the procedure of Jain [18] with slight modi-
fications. The thorax was opened to expose the aorta, and
the descending thoracic aorta from the heart to diaphragm
was dissected free. The isolated aortic tissue was immediately
submerged in Krebs solution, aerated with a mixture of 95%
O2 and 5% CO2 (carbogen). The surrounding connective
tissue and fat were carefully trimmed oﬀ, and the aorta
was then cut transversely into small rings of 2 to 4mm
length. Care was taken in isolating the tissue to avoid damage
to the endothelium. However, in the endothelium-denuded
group, the endothelium was removed by gently rubbing the
luminal surface of the vessels back and forth several times
with a polyethylene tubing (PE90). For each experiment a
pair of rings from the same aorta (one with and the other
without a functional endothelium) was used. Each of the
rings was suspended, by means of two parallel stainless
steel wires inserted into the lumen, in jacketed 10mL tissue
baths containing Krebs solution at 37◦C and aerated with
carbogen. The rings were each connected to an isometric
transducer (Grass Instrument Co., Quincy, MA), and the
transducer output was amplified and recorded continuously
by a MacLab version 4.0 recording system (AD Instrument,
Australia) coupled to a computer. The aortic rings were then
progressively stretched to a basal tension of 1 g and allowed
to equilibrate for 45 minutes. During this period the bathing
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solution was replaced every 15 minutes and, if needed, the
basal tone was readjusted to 1 g tension before the start of
experiment.
2.4.2. Aortic Tissue Viability and Endothelium Intactness. At
the end of equilibration period, each ring was challenged
with 60mM KCl in order to test for the contractility and via-
bility of the rings. This procedure was repeated at least once
or twice until the strength of two successive contractions
diﬀered by 10% or less. Once the viability of the rings was
established, contraction was induced by adding PE (1 μM)
into the bath. When a plateau was obtained, ACh (1 μM)
was then added to test the endothelial integrity. The ability
of ACh to induce at least 70% relaxation in the aortic rings of
WKY rats and 50% for SHR is used to verify the intactness
of the endothelium. A response of ≤10% ACh-induced
relaxation was taken to indicate that the endothelium had
been denuded [19].
2.5. Pharmacological Studies
2.5.1. Eﬀect of Citral and Extracts (LE, SE, and RE) on
Vascular Tension of Endothelial Intact SHR and WKY Rat
Aortic Rings on Phenylephrine- (PE-) Induced Contraction. In
the first series of experiments, the aortic rings were prepared
from both SHR and WKY rats. Following the primary
equilibration, the relaxant eﬀects of noncumulative addition
of citral (0.00624mM to 6.24mM) on the submaximal PE-
induced (1 μM) aortic ring muscle tone were examined. A
similar set of experiments was conducted using cumulative
addition of extracts (1, 3, 10, 30, and 100mg/mL) at 3-
minute interval between successive additions. The control
rings were similarly treated with PE but the corresponding
vehicle (2% methanol for citral or distilled water for the
extracts) was added instead. After each test, the rings were
washed repeatedly at least three times with fresh Krebs
solution and allowed to equilibrate for 30 minutes before
testing with KCl for their viability. Only data from rings that
remained viable at the end of the experiment were included
for statistical analysis.
2.5.2. Vasorelaxant Eﬀect of Citral and Extracts on PE-
Induced Contraction in Endothelial Intact SHR Aortic Ring
Pretreated with L-NAME and Indomethacin. The contribu-
tion of endothelium-derived relaxing factors such as nitric
oxide (NO) or cyclooxygenase-derived product such as
prostacyclin (PGI2) in the vascular response elicited by test
materials (citral and extracts) was examined by pretreatment
of SHR aortic rings with either nitro-L-arginine methyl ester
(L-NAME, 100 μM) or indomethacin (10 μM), respectively.
The aortic rings were exposed to these modulating agents for
20 minutes prior to studying the vasorelaxant eﬀects of the
test materials on PE-induced contraction.
2.5.3. Eﬀect of Citral and Extracts on Extracellular Ca2+-
Induced Contraction of Endothelial Intact and Denuded SHR
Aortic Rings. In order to determine whether the inhibition
of extracellular Ca2+ influx was involved in mediating the
vasorelaxant eﬀects of the extracts and citral, the experiment
was also performed in Ca2+-free Krebs solution. After
equilibration in the Ca2+-free Krebs solution for 20 minutes,
a cumulative concentration-response curve for CaCl2 (0.1,
0.5, 1.0, 1.5, 2.0, and 2.5mM) on PE-induced contraction
was constructed. The construction of this concentration-
response curve on the same aortic ring was repeated in
the presence of test materials, which were given 20 minutes
before PE was added. The data obtained in the absence of test
materials served as control. The maximal tension produced
by 2.5mM calcium in the control group was considered as
100%, following which the concentration-response curves
for the exogenously added calcium were constructed in the
absence and presence of test materials.
2.6. Data Analysis. All results are expressed as the mean ±
standard error of means (SEM) of 5 to 6 rats. The cumulative
and noncumulative relaxant responses caused by the extracts
and citral, respectively, were expressed as the percentage
relaxation relative to the maximal contraction induced by
1 μM PE. The diﬀerences in the response among the test
substances were analyzed for statistical significance using
Student’s t-test for paired and unpaired observations and
two-way analysis of variance. The PE-induced contraction
in Ca2+-free Krebs medium was measured by expressing the
magnitude of contraction obtained in the presence of test
substances versus contraction obtained in the absence of
test substances. In all cases the diﬀerences were considered
significant if P < 0.05.
3. Results
3.1. Eﬀect of Citral and Extracts (LE, SE, and RE) on Vascular
Tension of Endothelial Intact Rat Aortic Rings on PE-Induced
Contraction. The isolated rat aortic rings were precontracted
with PE to produce a sustained contractile response. As
shown in Figure 1, citral at doses ranging from 0.00624mM
to 6.24mM caused a concentration-dependent relaxation of
PE-induced (1 μM) contraction in SHR aortic rings com-
pared to the vehicle control (2% methanol). The relaxation
increased from 4.20 ± 0.02% to 39.13 ± 0.05%. However,
citral at the same concentrations tested on WKY rat aortic
rings did not cause a significant relaxation. In another
series of experiments, cumulative addition of LE, and RE
(from 0.1mg/mL to 100mg/mL) inhibited the contraction
evoked by PE in a concentration-dependent manner in both
SHR and WKY rat aortic rings (Figures 2(a) and 2(b)).
The LE induced relaxation up to 66.76 ± 6.75% in SHR
(IC50= 22.8mg/mL) and 64.92 ± 6.15% in WKY (IC50=
29.5mg/mL). Meanwhile, RE caused relaxation of up to
42.72± 5.79% in SHR and 38.8± 14.08% in WKY rat aortic
rings. On the other hand, SE, showed weaker relaxation
eﬀects in both types of rats. The results clearly demonstrated
that citral, LE, and RE produced relaxant eﬀect on aortic ring
smooth muscle. The question then arose as to how these test
materials exert their relaxant eﬀect. Moreover, the relaxant
eﬀect of citral and extracts at all concentrations used in
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Figure 1: Dose-response curves for vasorelaxation eﬀect of citral on
PE-induced contraction in endothelial intact aortic rings of SHR
and WKY rats. Values are shown as means ± S.E.M. with n = 6
rats, ∗P < 0.05, ∗∗P < 0.001 compared with the vehicle control, 2%
methanol.
this study was completely reversible suggesting that they are
devoid of toxic eﬀects.
3.2. Pharmacological Investigation
3.2.1. Vasorelaxant Eﬀect of Citral and Extracts on PE-Induced
Contraction in Endothelial Intact SHR Aortic Ring Pretreated
with L-NAME and Indomethacin. In the set of experiments
conducted to verify the possible involvement of NO acti-
vation in the relaxant eﬀect of citral, LE, or RE, the en-
dothelium intact rings (E+) were Pretreated with L-NAME
(100 μM) followed by the addition of PE to induce con-
traction and then test materials. As shown in Figure 3,
pretreating the rings with L-NAME caused the citral-induced
relaxation to be significantly attenuated from 26.15± 6.38%
to 7.19 ± 0.79% (P < 0.001). This finding indicated
that citral elicited vascular relaxation via NO-dependent
signalling mechanism, at least in part. In contrast, L-NAME
significantly augmented the relaxant eﬀect induced by RE
from 21.26 ± 1.73% to 43.03± 3.92%. L-NAME also caused
a similar change in the eﬀect of LE but the increase did not
reach the level of significance. In another set of experiments,
pretreating the E+ aortic rings with indomethacin (10 μM)
produced variable eﬀects: it did not alter the relaxant eﬀect
of citral but significantly enhanced the relaxant eﬀect of RE,
while it reversed the relaxant eﬀect of LE to cause instead
a significant increase in PE-induced contraction by 16.11 ±
1.78% (P < 0.001) (Figure 4).
3.2.2. Eﬀect of Citral and Extracts (LE and RE) on Extra-
cellular Ca2+-Induced Contraction of Endothelial Intact and
Denuded SHR Aortic Rings. The addition of CaCl2 (0.1mM
to 2.5mM) caused the transient PE-induced contraction of
the endothelium intact (E+) or denuded (E−) aortic rings
in Ca2+-free Krebs medium to increase in a dose-dependent
manner (Figure 5). Preincubation of the aortic rings with
citral, LE, and RE almost abolished this vasoactive eﬀect
of calcium. Thus, in the presence of citral, the addition of
calcium (0.1mM to 2.5mM) caused minimal change to the
contraction from 19.85± 3.66% at 0.1mM to 14.47± 4.05%
at 2.5mM in E+ and from 12.62 ± 4.94% at 0.1mM to
13.62 ± 10.00% at 2.5mM in E− aortic rings. Similarly,
LE and RE also greatly decreased (P < 0.001) the PE-
induced contraction of aortic ring in Ca2+-free Krebs, and
the addition of increasing doses of calcium did not augment
the contraction.
4. Discussion
In the present study, the extracts (leaves, stems, and roots)
from C. citratus were prepared as methanolic extracts.
Despite the traditional practice of using aqueous extracts,
methanol was chosen as the solvent so as not to miss any
possible active compounds since it will dissolve both polar
and some nonpolar constituents [20]. In addition, methanol
is a common water-miscible solvent, and the solubility per-
centage in water is 100% with polarity index of 5.1 [21]. It
needs to be pointed out that the methanol was evaporated
and the dried extract residue was subsequently reconstituted
in distilled H2O for all studies using the aortic ring prepara-
tion.
This paper reports the vasorelaxant properties of citral
and methanolic extracts of leaf (LE), stem (SE), and root
(RE) of C. citratus using isolated rat aortic rings and the pos-
sible mechanism(s) involved. The present observation of the
vasorelaxant eﬀect of citral on the PE-induced contraction
in SHR aortic rings was in agreement with earlier studies
that reported vasodilatory and antihypertensive eﬀects of
terpenoids [22]. A similar eﬀect was shown by the leaf and
root extracts suggesting that citral may be the main constit-
uent in these extracts. The current study, however, indicates
the presence of other compounds in both the leaf and root
extracts since the vasorelaxant eﬀect was observed in the
aortic rings of both SHR and WKY rats, whereas citral
showed the eﬀect only in SHR.
Citral, LE, and RE significantly attenuated the con-
tractile response induced by the selective α1-adrenoceptor
agonist, PE, suggesting that these test materials may mod-
ulate the endothelial-derived relaxing factors (EDRFs) that
include endothelial-derived NO (EDNO) and prostacyclin
(PGI2)/prostaglandins [20, 23]. It is well established that NO
is a major EDRF that plays a central role in the maintenance
of vascular tone [24, 25]. When released from the endothe-
lium, NO diﬀuses into the smooth muscle and then triggers
the formation of cyclic guanosine monophosphate (cGMP),
increasing the cGMP levels that lead to vasorelaxation. A
reduced NO production by vascular endothelial cell is closely
associated with endothelial disease or injury that has been
proposed to be an important causative factor in cardiovascu-
lar diseases, especially in the development of arteriosclerosis
and hypertension [26].
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Figure 2: Dose-response curves for the vasorelaxation eﬀect of extracts from leaves (LE), stems (SE), and roots (RE) on PE-induced
contractions in aortic rings of (a) SHR and (b) WKY rats. Values are shown as means ± S.E.M. with n = 6 rats, ∗P < 0.05, ∗∗P < 0.001
compared with vehicle control, distilled water.
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Figure 3: Eﬀect of 6.24mM citral and 30mg/mL of extracts from
leaves (LE) and roots (RE) of C. citratus on PE-induced contraction
in the absence (−) and presence (+) of L-NAME (100 μM) in
endothelium intact aortic rings of SHR rats. Values are shown as
means S.E.M. with n = 5-6 rats.
The involvement of NO in the relaxant eﬀect produced
by citral, LE, and RE in isolated aortic rings was investigated
by incubating the E+ rings with the NO synthase inhibitor,
L-NAME, prior to inducing contraction with PE and the
subsequent addition of the test materials. The citral-induced
smooth muscle relaxation on the PE-contracted rings was
observed to be significantly reduced in the presence of L-
NAME. These data provided evidence that NO may be
involved in the vasorelaxant eﬀect of citral. It also supports
the hypothesis that citral may stimulate endothelial NO pro-
duction and/or release. Whether citral is directly interacting
with endothelial NO synthase or with other factors, which
may increase the endothelial NO synthase activity, remains
to be further investigated. Under the same condition, the
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Figure 4: Eﬀect of 6.24mM citral and 30mg/mL of extracts from
leaves (LE) and roots (RE) of C. citratus on PE-induced contraction
in the absence (−) and presence (+) of indomethacin (10 μM) in
endothelial intact aortic rings of SHR rats. Values are shown as
means ± S.E.M. with n = 5 rats, ∗∗P < 0.001.
relaxation caused by LE and RE was not attenuated. These
results suggest that NO, a modulator of the vascular function
[27], may partially play a role in the vasodilator eﬀect of citral
but not that of LE and RE. In fact, RE caused a significantly
greater relaxant eﬀect in the presence of L-NAME. The
reason for this change remains to be elucidated.
Besides NO, prostaglandin (PG) is also produced by
endothelial cells to counteract the vasoconstriction induced
by the sympathetic nerve endings and humoral vasoconstric-
tors. After the discovery of EDRF, it was demonstrated that
endothelial cells also can generate cyclooxygenase- (COX-)
derived vasoconstrictor substances in canine veins and in
arteries of SHR [28]. Thus, by secreting relaxing and
constricting factors, the endothelium can induce dilation
or constriction in response to sheer stress and a variety of
endogenous vasoactive substances that are either produced
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Figure 5: Dose-response curves for calcium in the presence and absence of (a) 6.24mM citral and (b) 30mg/mL of the extract from
leaves (LE) and (c) roots (RE) of C. citratus on the PE-induced contraction in Ca2+-free Krebs solution in endothelial intact (E+) and
endothelial denuded (E−) aortic rings of SHR rats. All the data were significant at ∗∗P < 0.001 compared to the PE-induced contraction in
the corresponding E+ and E− aortic rings. Values were shown as means ± S.E.M. with n = 6 rats.
systemically or generated locally by vascular tissues or
circulating in the blood.
Prostacyclin (PGI2), a major vasodilatory COX product,
is produced by the intimal layers of the vascular wall [27,
29]. In the present study, the involvement of PGI2 in the
relaxant eﬀect of the test materials on intact aortic ring
preparations was investigated by preincubating the rings with
indomethacin. Indomethacin is an inhibitor of COX and
will inhibit the synthesis of various PGs including PGI2
and markedly inhibits the transient relaxation induced by
arachidonic acid [30]. Indomethacin did not seem to aﬀect
the relaxant eﬀect of citral. On the other hand, the relaxant
eﬀect produced by RE was significantly increased, thus,
suggesting that PGI2 did not play an important role in the
vasorelaxant response induced by RE. We cannot oﬀer a
good explanation for the increased vasorelaxant eﬀect in
this paper. Perhaps RE contains a non-PG vasodilator and
a small amount of vasoconstricting PG such as thromboxane
A2 such that in the presence of indomethacin the opposing
vasoconstrictor response was removed giving rise to a net
increase in vasorelaxant response.
Interestingly, the presence of indomethacin caused a
reversal of the relaxant eﬀect of LE, causing instead a con-
traction of the aortic rings. It could be postulated that the LE
may have a vasoconstrictor as well as vasorelaxant agents as
its constituents and that the relaxant eﬀect is more dominant.
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The relaxant eﬀect may partly be due to PGI2 or other PGs,
and when the synthesis of PGs was inhibited by indometh-
acin, the non-PG vasoconstrictor eﬀect became unmasked
giving rise to contraction.
As with other muscles, the smooth muscle requires
Ca2+ to contract. It is well established that the influx of
external Ca2+ through specific Ca2+ channels or Ca2+ release
from internal stores plays an important role in excitation-
contraction coupling of smooth muscles. By binding to spe-
cific membrane receptors, PE induces Ca2+ influx through
receptor-operated channels causing tonic contraction [31,
32] and stimulates the formation of inositol triphosphate
(IP3) that binds to and opens specific IP3-receptor channels
in the sarcoplasmic reticulum membrane, inducing Ca2+
release from intracellular storage sites and causing phasic
contraction [32, 33].
When the aortic rings were incubated in a Ca2+-free
Krebs solution and PE was added into the bath there was
a transient increase in contraction due to release of Ca2+
from intracellular storage sites. The addition of increasing
doses of CaCl2 solution into the organ bath caused a dose-
dependent increase in contraction of both the E+ and E−
aortic rings. However, when the rings were Pretreated with
citral, LE, and RE, both the transient PE-induced contraction
and the CaCl2-induced contraction were abrogated. Based
on these findings, it may be postulated that citral, LE, and
RE can either block the entry of Ca2+ from the extracellular
space possibly via receptor-operated calcium channel or the
Ca2+ release from intracellular storage sites. Further studies
are required to understand the exact mechanism by which
citral and the extracts aﬀect the intracellular Ca2+ levels.
5. Conclusion
In summary, citral and the methanolic extracts of leaves and
roots from C. citratus elicited relaxation on vascular smooth
muscle. The present study demonstrated, for the first time,
that citral is able to produce vasorelaxation in rat aorta,
which appeared to be through NO pathway and blockade
of calcium channels. Meanwhile, the methanolic extracts
from leaves and roots were observed to exert vasorelaxation
via blockade of calcium channels. The leaf extract may also
cause relaxation of vascular smooth muscle through PGI2
since inhibition of its synthesis by indomethacin resulted
in contraction. However, the exact mode of action on the
vasorelaxant eﬀect caused by these test materials remains
to be investigated. The findings from this study provide a
scientific basis for the use of this plant in traditional medicine
and merits further investigations.
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